While CCNB1 and CHEK1 showed decreased eigenvector centrality in metastasis, CHEK1 plays a key role in the DNA damage response [32] and contributes to tumor progression and therapy resistance in PCa, particularly in metastatic castration-resistant prostate cancer (CRPC) [33]. Here, CCNB1 is linked to posterior cortical atrophy.